Head-Neck Tumor Board is designed to review existing cases and apply the most current evidence-based knowledge and guidelines to establish treatment plans for improved patient outcomes.  

OBJECTIVES: Upon completion of this activity, the participant should be able to: 

  • Decide when surgery, chemo and/or radiation should be used for treatment for the specific patients
  • Introduce new pathological tests that can provide prognostic indicators for treatment decisions
  • Identify new drugs and/or treatment modalities and formulate the best treatment plan for patient cases discussed
  • Review the latest NCCN Guidelines and ASCO Guidelines

PLANNER/MODERATOR DISCLOSURE: The planners have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Christy Morgan at Christy.Morgan@BSWHealth.org 

Meeting Link:
Temple H&N Tumor Board Meeting

Session date: 
02/14/2024 - 12:00pm to 1:00pm CST
Location: 
Temple, TX
United States
  • 1.00 AMA PRA Category 1 Credit
    The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Attendance

Please login or register for this course.